Boiron (OTCMKTS: BOIRF) is a France-based manufacturer and distributor of homeopathic medicines. Established in 1932 by the Boiron brothers in Lyon, the company has grown into a global leader in homeopathy, offering a wide range of over 200 medicines designed for self-medication. Boiron’s portfolio addresses common ailments such as colds, flu-like symptoms, muscle soreness and teething discomfort, underscoring its focus on accessible, non-prescription treatments.
The company’s products are formulated in various forms, including pellets, tablets, gels, creams, ointments and nasal sprays. Boiron operates dedicated research and development facilities to ensure adherence to quality and safety standards, with its manufacturing sites certified under Good Manufacturing Practices (GMP). Signature products such as Oscillococcinum for flu relief and Arnica montana for muscle pain have become staples in its global offering.
Boiron maintains a commercial presence in more than 50 countries through a network of over 30 affiliates and partnerships with distributors, supporting distribution in North America, Europe, Asia and Latin America. Its U.S. subsidiary, Boiron USA, is headquartered in West Chester, Pennsylvania, where it coordinates marketing and regulatory affairs for the North American region. Additional production sites in France, Canada and Germany bolster the company’s ability to serve diverse markets.
Governed by an executive management team and a board of directors, Boiron retains its founding family’s commitment to homeopathic innovation while operating as a publicly listed company in Paris. The company continues to invest in product development, education and regulatory engagement to advance homeopathy’s role within the broader healthcare landscape.
AI Generated. May Contain Errors.
